Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Matrix protein 2 ectodomain (M2e) is a highly conserved 24-amino acid sequence located at the N-terminus of the Influenza A virus M2 protein (UniProt P06821). While the full M2 protein functions as a pH-gated proton channel essential for viral uncoating and assembly, the M2e region is exposed on the surface of the virion and infected cells, making it a prime target for universal influenza vaccine development. Unlike the rapidly mutating hemagglutinin and neuraminidase proteins, M2e remains remarkably stable across various influenza A subtypes, including H1N1 and H5N1. Therapeutic strategies targeting M2e include monoclonal antibodies like TCN-032 and recombinant vaccines designed to elicit a broad immune response. These interventions typically rely on Fc-mediated effector functions, such as antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, to eliminate infected host cells and reduce viral shedding. Despite its potential, M2e is poorly immunogenic during natural infection, necessitating the use of carriers or adjuvants in clinical applications. Research continues to focus on M2e to provide cross-protection against both seasonal and pandemic influenza strains.
M2e-targeting antibodies primarily facilitate viral clearance through Fc-mediated effector functions, including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), while small molecule inhibitors like amantadine block the M2 proton channel activity to prevent viral genome release.
4 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza A virus Matrix protein 2 ectodomain (M2e) (M2e).